Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04XBU
|
|||
| Former ID |
DIB002173
|
|||
| Drug Name |
ATL-104
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Receptor unspecific (Rec) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00163280) Safety, Tolerability and Efficacy of ATL-104 in Oral Mucositis. U.S. National Institutes of Health. | |||
| REF 2 | Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial. Bone Marrow Transplant. 2009 Apr;43(7):563-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.